Board of Directors

James R. Trusler

Chief Executive Officer, President, Chairman of the Board, Founder, Promoter, Director

Chairman of the Board of the Company, 1998 to present; CEO and President of the Company 1998-2018, 2019 to present; President, J. R. Trusler & Associates (mineral consultant), 1995 to present.

Lorne D. Burden

Director; Member, Compensation Committee

Consulting Geologist, 2014 to present; Manager Corporate Development/Senior Geologist Logistics Royal Nickel Corporation 2007 to 2014; Associate Consulting Geologist with ACA Howe International Limited, 2005-2007

Robert Blake III

Co-CEO, Director

Robert Blake III, was raised in New York City where he graduated from The Collegiate School. He has a B.A. Economics degree from Brown University and an M.B.A. in finance from The Wharton School of the University of Pennsylvania. Also, Robert has been an advisor to physicians, manager of health care operations, and a health care investor for more than thirty (30) years. In 2013 with the passage of new legislation and after months of research regarding the medicinal benefits off cannabinoids, Bob invested in the Oregon cannabis industry. His investments began with vertically integrated operations of a grow facility, an extraction processor, and a dispensary. His Oregon cannabis holdings now include multiple grow facilities and dispensaries, an extraction processor, and a wholesale operation.

Robert Schwartz

Director

Robert Schwartz is and has been a serial entrepreneur with over 15 years of experience in manufacturing and global distribution as well as experience in financing micro-cap companies from inception/incubator stage to public markets. Mr. Schwartz is currently a director of Lineage Grow Company Ltd. (CSE BUDD) and is also a director at Aura Health Corp. Mr. Schwartz has invested, consulted or operated in over 15 cannabis companies internationally.

Gary Galitsky

Director; Member, Compensation Committee

Gary Galitsky is the President and a Director of Xanthic Biopharma Inc. (CSE: XTHC). Mr. Galitsky has been producing craft cannabis for designated use for 7 years and has extensive expertise in cannabis extraction techniques. Mr. Galitsky was one of the earliest applicants to receive a Canadian Marihuana Medical Access Regulations license for both personal and designated production. He has consulted for several licensed medical cannabis producers to develop both scaled plant production growth strategy as well as extraction and secondary processes.